2020 Q1 Form 10-Q Financial Statement

#000156459020024151 Filed on May 11, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q1
Revenue $4.244M $6.551M
YoY Change -35.22% 12.68%
Cost Of Revenue $590.0K $1.890M
YoY Change -68.78% 127.71%
Gross Profit $3.660M $4.660M
YoY Change -21.46% -6.61%
Gross Profit Margin 86.24% 71.13%
Selling, General & Admin $3.472M $3.925M
YoY Change -11.54% 12.14%
% of Gross Profit 94.86% 84.23%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $90.00K $80.00K
YoY Change 12.5% 0.0%
% of Gross Profit 2.46% 1.72%
Operating Expenses $3.472M $3.925M
YoY Change -11.54% 9.64%
Operating Profit $188.0K $659.0K
YoY Change -71.47% -53.1%
Interest Expense -$30.00K -$20.00K
YoY Change 50.0% -83.33%
% of Operating Profit -15.96% -3.03%
Other Income/Expense, Net
YoY Change
Pretax Income $70.00K $636.0K
YoY Change -88.99% -50.66%
Income Tax $29.00K $24.00K
% Of Pretax Income 41.43% 3.77%
Net Earnings $38.00K $612.0K
YoY Change -93.79% -52.52%
Net Earnings / Revenue 0.9% 9.34%
Basic Earnings Per Share $0.00 $0.02
Diluted Earnings Per Share $0.00 $0.02
COMMON SHARES
Basic Shares Outstanding 28.75M 28.65M
Diluted Shares Outstanding 30.20M 28.81M

Balance Sheet

Concept 2020 Q1 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.090M $1.840M
YoY Change 67.93% 15.0%
Cash & Equivalents $3.093M $1.836M
Short-Term Investments
Other Short-Term Assets $1.060M $670.0K
YoY Change 58.21% 71.79%
Inventory $220.0K $1.530M
Prepaid Expenses
Receivables $1.700M $1.326M
Other Receivables $820.0K $0.00
Total Short-Term Assets $6.880M $5.360M
YoY Change 28.36% 35.01%
LONG-TERM ASSETS
Property, Plant & Equipment $1.560M $1.270M
YoY Change 22.83% 605.56%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $2.770M $2.767M
YoY Change 0.11%
Other Assets $600.0K $220.0K
YoY Change 172.73% -12.0%
Total Long-Term Assets $14.79M $13.98M
YoY Change 5.79% 34.42%
TOTAL ASSETS
Total Short-Term Assets $6.880M $5.360M
Total Long-Term Assets $14.79M $13.98M
Total Assets $21.67M $19.34M
YoY Change 12.05% 34.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.980M $5.580M
YoY Change 43.01% 19.74%
Accrued Expenses $580.0K $530.0K
YoY Change 9.43%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $340.0K $1.180M
YoY Change -71.19% 100.0%
Total Short-Term Liabilities $8.903M $7.840M
YoY Change 13.56% -5.08%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $340.0K
YoY Change -100.0% -55.26%
Other Long-Term Liabilities $810.0K $1.662M
YoY Change -51.26%
Total Long-Term Liabilities $810.0K $1.662M
YoY Change -51.26% 118.68%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.903M $7.840M
Total Long-Term Liabilities $810.0K $1.662M
Total Liabilities $9.710M $11.06M
YoY Change -12.21% 16.05%
SHAREHOLDERS EQUITY
Retained Earnings -$276.8M
YoY Change
Common Stock $293.0K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $11.96M $8.283M
YoY Change
Total Liabilities & Shareholders Equity $21.67M $19.34M
YoY Change 12.04% 34.59%

Cashflow Statement

Concept 2020 Q1 2019 Q1
OPERATING ACTIVITIES
Net Income $38.00K $612.0K
YoY Change -93.79% -52.52%
Depreciation, Depletion And Amortization $90.00K $80.00K
YoY Change 12.5% 0.0%
Cash From Operating Activities -$118.0K -$2.335M
YoY Change -94.95% 752.19%
INVESTING ACTIVITIES
Capital Expenditures $5.000K $5.000K
YoY Change 0.0% -91.23%
Acquisitions
YoY Change
Other Investing Activities $590.0K
YoY Change
Cash From Investing Activities $581.0K -$5.000K
YoY Change -11720.0% -91.23%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -98.00K -92.00K
YoY Change 6.52% -49.45%
NET CHANGE
Cash From Operating Activities -118.0K -2.335M
Cash From Investing Activities 581.0K -5.000K
Cash From Financing Activities -98.00K -92.00K
Net Change In Cash 365.0K -2.432M
YoY Change -115.01% 374.07%
FREE CASH FLOW
Cash From Operating Activities -$118.0K -$2.335M
Capital Expenditures $5.000K $5.000K
Free Cash Flow -$123.0K -$2.340M
YoY Change -94.74% 606.95%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
8903000
CY2020Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
805000
CY2019Q4 us-gaap Liabilities
Liabilities
10070000
CY2020Q1 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
329000
CY2019Q4 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
372000
CY2020Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3000
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
9093000
CY2019Q4 us-gaap Unsecured Long Term Debt
UnsecuredLongTermDebt
35000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
942000
CY2020Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
90000
CY2019Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
76000
CY2020Q1 us-gaap Costs And Expenses
CostsAndExpenses
4151000
CY2019Q1 us-gaap Costs And Expenses
CostsAndExpenses
5892000
CY2020Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3472000
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
24000
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
75000
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
71000
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-160000
CY2019Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
926000
CY2020Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
114000
CY2019Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-879000
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
333000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4268000
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
29000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
38000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
612000
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28751689
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28653278
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30200114
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28814149
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
-2000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
75000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
7600000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
38000
CY2019Q1 us-gaap Profit Loss
ProfitLoss
612000
CY2020Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
59000
CY2019Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
0
CY2019Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0
CY2020Q1 hgbl Noncash Lease Expense
NoncashLeaseExpense
131000
CY2019Q1 hgbl Noncash Lease Expense
NoncashLeaseExpense
117000
CY2020Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
43000
CY2019Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2019Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
63000
CY2020Q1 hgbl Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
-134000
CY2019Q1 hgbl Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
-122000
CY2020Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
0
CY2019Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-455000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-118000
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2335000
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5000
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5000
CY2020Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
385000
CY2019Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
0
CY2020Q1 us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
136000
CY2019Q1 us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
0
CY2020Q1 us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
3580000
CY2019Q1 us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
0
CY2020Q1 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
421000
CY2019Q1 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
0
CY2020Q1 hgbl Cash Received On Transfer Of Notes Receivable To Partners
CashReceivedOnTransferOfNotesReceivableToPartners
3994000
CY2019Q1 hgbl Cash Received On Transfer Of Notes Receivable To Partners
CashReceivedOnTransferOfNotesReceivableToPartners
0
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
581000
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5000
CY2020Q1 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
4425000
CY2020Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
100000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
385000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
278000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
218000
CY2019Q1 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
92000
CY2019Q1 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
0
CY2020Q1 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
4523000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-98000
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-92000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
365000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-2432000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2728000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3093000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1836000
CY2020Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
2000
CY2019Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
1000
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
29000
CY2019Q1 us-gaap Interest Paid Net
InterestPaidNet
16000
CY2020Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of the Company&#8217;s consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period. Management bases its estimates and judgments on historical experience and various other factors that are believed to be reasonable under the circumstances. Actual results could differ from those estimates.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Significant estimates include the assessment of collectability of revenue recognized, and the valuation of accounts receivable, inventory, other assets, right-of-use assets, goodwill and intangible assets, liabilities, deferred income tax assets and liabilities, and stock-based compensation. These estimates have the potential to significantly impact the Company&#8217;s consolidated financial statements, either because of the significance of the financial statement item to which they relate, or because they require judgment and estimation due to the uncertainty involved in measuring, at a specific point in time, events that are continuous in nature.</p>
CY2020Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Reclassifications </p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain prior year balances within the condensed consolidated financial statements have been reclassified to conform to the current year presentation.</p>
CY2020Q1 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
1800000
CY2019Q4 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
2700000
CY2020Q1 us-gaap Notes Issued1
NotesIssued1
3600000
CY2020Q1 us-gaap Proceeds From Sale Of Notes Receivable
ProceedsFromSaleOfNotesReceivable
400000
CY2020Q1 hgbl Deferred Fees And Costs
DeferredFeesAndCosts
100000
CY2020Q1 hgbl Closing Amount Of Revolving Credit Facility
ClosingAmountOfRevolvingCreditFacility
6000000
CY2020Q1 hgbl Notes Receivable Balance Of Certain Loans Transferred To Partner
NotesReceivableBalanceOfCertainLoansTransferredToPartner
1000000
CY2020Q1 hgbl Notes Receivable Balance Of Certain Loans Transferred To Joint Venture
NotesReceivableBalanceOfCertainLoansTransferredToJointVenture
3000000
CY2020Q1 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
0
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
102025
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
114750
CY2020Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
43875
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
102025
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3580700
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2156961
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.46
CY2020Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.89
CY2020Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.45
CY2020Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.56
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.52
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.46
CY2019Q2 us-gaap Sale Leaseback Transaction Date
SaleLeasebackTransactionDate
The purchase option for both the real estate and machinery and equipment can be exercised at any time on or after December 1, 2019 and before May 31, 2021.
CY2019Q2 us-gaap Sale Leaseback Transaction Net Book Value
SaleLeasebackTransactionNetBookValue
20000000
CY2020Q1 us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
327000
CY2020Q1 us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
8000
CY2020Q1 us-gaap Equity Method Investment Summarized Financial Information Assets
EquityMethodInvestmentSummarizedFinancialInformationAssets
25021000
CY2019Q4 us-gaap Equity Method Investment Summarized Financial Information Assets
EquityMethodInvestmentSummarizedFinancialInformationAssets
21618000
CY2020Q1 us-gaap Equity Method Investment Summarized Financial Information Liabilities
EquityMethodInvestmentSummarizedFinancialInformationLiabilities
11131000
CY2019Q4 us-gaap Equity Method Investment Summarized Financial Information Liabilities
EquityMethodInvestmentSummarizedFinancialInformationLiabilities
11042000
CY2020Q1 us-gaap Convertible Preferred Stock Terms Of Conversion
ConvertiblePreferredStockTermsOfConversion
The Company's Class N preferred shares, each of which is convertible to 40 common shares, have the right to receive dividends or dividend equivalents should the Company declare dividends on its common stock.
CY2020Q1 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
40
CY2020Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1448425
CY2019Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
160871
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
100000
CY2019Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
300000
CY2020Q1 hgbl Number Of Locations
NumberOfLocations
3
CY2020Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
1385000
CY2019Q1 hgbl Lessee Operating Lease Incremental Borrowing Rate
LesseeOperatingLeaseIncrementalBorrowingRate
0.0525
CY2019Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
100000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
428000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
176000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
30000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1515000
CY2020Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
130000
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
955000
CY2020Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
67000
CY2020Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
888000
CY2019Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
100000
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
201000
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
270000
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
159000
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
129000
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
129000
CY2020Q1 us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0
CY2020Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2020Q1 us-gaap Loans Payable
LoansPayable
340000
CY2019Q4 us-gaap Loans Payable
LoansPayable
438000
CY2020Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
86000000
CY2020Q1 us-gaap Tax Credit Carryforward Amount
TaxCreditCarryforwardAmount
100000
CY2020Q1 us-gaap Operating Loss Carryforwards Limitations On Use
OperatingLossCarryforwardsLimitationsOnUse
The Company’s utilization of restricted net operating tax loss carry forwards against future income for tax purposes is restricted pursuant to the “change in ownership” rules in Section 382 of the Internal Revenue Code.
CY2020Q1 hgbl Operating Loss Carryforwards Expiration
OperatingLossCarryforwardsExpiration
Substantially all of the net operating loss carry forwards and unused minimum tax credit carry forwards expire between 2024 and 2037.

Files In Submission

Name View Source Status
0001564590-20-024151-index-headers.html Edgar Link pending
0001564590-20-024151-index.html Edgar Link pending
0001564590-20-024151.txt Edgar Link pending
0001564590-20-024151-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gjm0nkfbb5vu000001.jpg Edgar Link pending
hgbl-10q_20200331.htm Edgar Link pending
hgbl-20200331.xml Edgar Link completed
hgbl-20200331.xsd Edgar Link pending
hgbl-20200331_cal.xml Edgar Link unprocessable
hgbl-20200331_def.xml Edgar Link unprocessable
hgbl-20200331_lab.xml Edgar Link unprocessable
hgbl-20200331_pre.xml Edgar Link unprocessable
hgbl-ex311_7.htm Edgar Link pending
hgbl-ex312_6.htm Edgar Link pending
hgbl-ex321_8.htm Edgar Link pending
hgbl-ex322_10.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending